Palleon presents data on sialoglycan degradation platform that enhances anti-tumor T-cell immunity

Clinical Impact

Nov 9

Written By Frances Benson

https://palleonpharma.com/press-releases/palleon-presents-data-on-sialoglycan-degradation-platform-that-enhances-anti-tumor-t-cell-immunity/

2021

Frances Benson

CRISPR Therapeutics announces FDA Regenerative Medicine Advanced Therapy (RMAT) designation granted to CTX110™

Tranquis Therapeutics presents positive preclinical data on TQS-168 for the treatment of ALS